MMTX — MindMaze Therapeutics Holding SA Share News
0.000.00%
Last trade - 00:00- CH₣34.12m
- CH₣24.65m
- CH₣0.64m
Brief: Relief Therapeutics Shareholders Approve Business Combination With Neurox
Brief: Relief Therapeutics Receives FDA Response To Qidp Request For Rlf-Td011
Brief: Relief Therapeutics Says Interim CEO Michelle Lock Has Completed Her Transitional Mandate
Swiss stocks - Factors to watch on May 13
Brief: Eton Pharmaceuticals Announces Acquisition Of Pku Golike® For Phenylketonuria
Brief: Relief Therapeutics Holding SA: Renews CHF 50 Million Share Subscription Facility
Brief: Relief Therapeutics Renews CHF 50 Million Share Subscription Facility
Brief: Relief Therapeutics: Shifts Commercial Operations To Partnership Model
Brief: Relief Therapeutics: Michelle Lock Assumes CEO Role On Interim Basis
Swiss stocks - Factors to watch on August 31
Brief: Relief Therapeutics Announces New Exclusive Definitive License Agreement For Olpruva With Acer Therapeutics
Brief: Relief Therapeutics: Extension Of Distribution Agreement For Pku Golike In U.S. With Pentec Health
Brief: Six Group Fines Relief Therapeutics Over Adhoc Publicity Violation
Brief: Relief Therapeutics Says Olpruva Commercial Launch Progressing Ahead Of Schedule
Swiss stocks - Factors to watch on April 14
Brief: Relief Therapeutics: Plans Reverse Split Of Company's Ordinary Shares
Brief: Relief Therapeutics Holding SA Files To Withdraw U.S. IPO Plans – SEC Filing
Brief: Relief Therapeutics Announces IRB Approval Of Investigator-Initiated Trial Evaluating RLF-TD011
Brief: Acer Therapeutics And Relief Therapeutics Announce U.S. FDA Approval Of Olpruva